Clover Health/$CLOV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Clover Health
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Ticker
$CLOV
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
570
ISIN
US18914F1030
Website
Clover Health Metrics
BasicAdvanced
$1.6B
-
-$0.05
1.93
-
Price and volume
Market cap
$1.6B
Beta
1.93
52-week high
$4.87
52-week low
$1.34
Average daily volume
9.7M
Financial strength
Current ratio
1.537
Quick ratio
1.383
Profitability
EBITDA (TTM)
-22.906
Gross margin (TTM)
26.37%
Net profit margin (TTM)
-1.69%
Operating margin (TTM)
-1.64%
Revenue per employee (TTM)
$2,610,000
Management effectiveness
Return on assets (TTM)
-2.43%
Return on equity (TTM)
-7.75%
Valuation
Price to revenue (TTM)
1.011
Price to book
4.6
Price to tangible book (TTM)
4.64
Price to free cash flow (TTM)
-173.148
Free cash flow yield (TTM)
-0.58%
Free cash flow per share (TTM)
-1.76%
Growth
Revenue change (TTM)
15.62%
Earnings per share change (TTM)
-84.57%
3-year revenue growth (CAGR)
-10.53%
3-year earnings per share growth (CAGR)
-66.91%
What the Analysts think about Clover Health
Analyst ratings (Buy, Hold, Sell) for Clover Health stock.
Bulls say / Bears say
Clover Health achieved its first quarterly net income of $7.2 million in Q2 2024, indicating a significant turnaround in financial performance. (Fierce Healthcare)
The company reported a 27% growth in Medicare Advantage membership, surpassing 100,000 lives after a strong annual election period in January 2025. (Clover Health)
Clover Health's proprietary AI platform, Clover Assistant, has been deployed with leading healthcare organizations, enhancing clinical data access and potentially improving patient outcomes. (Clover Health)
Despite recent profitability, Clover Health reported a net loss of $8.8 million in Q3 2024, highlighting ongoing financial challenges. (Fierce Healthcare)
The company's Insurance Medical Cost Ratio (MCR) improved to 81.2% in 2024 but remains a critical metric to monitor, as higher MCRs can impact profitability. (Fierce Healthcare)
Clover Health's reliance on technology-driven models in the competitive Medicare Advantage market poses risks if technological adoption or integration faces challenges. (Fierce Healthcare)
Data summarised monthly by Lightyear AI. Last updated on 7 Jul 2025.
Clover Health Financial Performance
Revenues and expenses
Clover Health Earnings Performance
Company profitability
Clover Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Clover Health stock?
Clover Health (CLOV) has a market cap of $1.6B as of July 11, 2025.
What is the P/E ratio for Clover Health stock?
The price to earnings (P/E) ratio for Clover Health (CLOV) stock is 0 as of July 11, 2025.
Does Clover Health stock pay dividends?
No, Clover Health (CLOV) stock does not pay dividends to its shareholders as of July 11, 2025.
When is the next Clover Health dividend payment date?
Clover Health (CLOV) stock does not pay dividends to its shareholders.
What is the beta indicator for Clover Health?
Clover Health (CLOV) has a beta rating of 1.93. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.